Details for Patent: 10,507,295

✉ Email this page to a colleague

Which drugs does patent 10,507,295 protect, and when does it expire?

Patent 10,507,295 protects TRUDHESA and is included in one NDA.

This patent has eighteen patent family members in eight countries.

Summary for Patent: 10,507,295

Patent landscape, scope, and claims:

Title:	Nasal drug delivery device
Abstract:	A compound delivery device for delivering a plume derived from a propellant and a drug formulation. The drug formulation is in an intranasal dosage form in the form of powder, suspension, dispersion or liquid. The propelled intranasal dosage form is deposited within the olfactory region of the nasal cavity. The drug deposited within the olfactory region is delivered to the brain avoiding the blood-brain-barrier. Hydrofluoroalkane propellant from a pressurized canister is channeled to a diffuser and drug-containing chamber where the intra-nasal dosage form is aerosolized. The aerosolized intra-nasal dosage form passes through a nozzle thus delivering a plume to the olfactory region of a user's nasal cavity.
Inventor(s):	Hoekman; John D. (Seattle, WA), Hite; Michael (Normandy Park, WA), Brunelle; Alan (Woodinville, WA), Relethford; Joel (Everett, WA), Ho; Rodney J. Y. (Mercer Island, WA)
Assignee:	Impel Neuropharma, Inc. (Seattle, WA)
Application Number:	15/338,097
Patent Claim Types: see list of patent claims	Compound; Delivery; Device; Dosage form;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 10,507,295

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Impel Pharms	TRUDHESA	dihydroergotamine mesylate	SPRAY, METERED;NASAL	213436-001	Sep 2, 2021		RX	Yes	Yes	10,507,295	⤷ Subscribe	Y				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 10,507,295

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2012223160	⤷ Subscribe
Australia	2016256665	⤷ Subscribe
Australia	2018256518	⤷ Subscribe
Brazil	112013022249	⤷ Subscribe
Brazil	122021002471	⤷ Subscribe
Canada	2828884	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.